Sulforaphane protects against acrolein-induced oxidative stress and inflammatory responses: Modulation of Nrf-2 and COX-2 expression

Archives of Medical Science

Volumn 12, Issue 4, 2016, Pages 871-880

  Qin, Wang Sen ^a   Deng, Yu Hui ^a   Cui, Fa Cai ^a  

^a HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Acrolein; Inflammation; Oxidative stress; Sulforaphane

Indexed keywords

ACROLEIN; CATALASE; CYCLOOXYGENASE 2; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; LACTATE DEHYDROGENASE; PEPTIDES AND PROTEINS; PROSTAGLANDIN E2; PROTEIN CARBONYL; REACTIVE OXYGEN METABOLITE; SULFORAPHANE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOL DERIVATIVE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME RELEASE; HUMAN; HUMAN CELL; IC50; IN VITRO STUDY; LIPID PEROXIDATION; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN CONTENT; PROTEIN EXPRESSION; UPREGULATION;

EID: 84977276981     PISSN: 17341922     EISSN: 18969151     Source Type: Journal    
DOI: 10.5114/aoms.2016.59919     Document Type: Article

References (70)

1. Kehrer J P, Biswal SS: The molecular Effects of acrolein. Toxicol Sci 2000; 57: 6-15.
2. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biol Med 1991; 11: 81-128.
3. Logue JM, Price PN, Sherman MH, Singer BC. A method to estimate the chronic health impact of air pollutants in U.S. residences. Environ Health Perspect 2012; 120: 216-22.
4. Borchers MT, Wesselkamper S, Wert SE, Shapiro SD, Leikauf GD. Monocyte infammation augments acro-lein-induced Muc5ac expression in mouse lung. Am J Physiol 1999, 277: L489-97.
5. Park YS, Taniguchi N. Acrolein induces infammatory response underlying endothelial dysfunction: a risk factor for atherosclerosis. Ann N Y Acad Sci 2008; 1126: 185-9.
6. Pugazhenthi S, Phansalkar K, Audesirk G, West A, Cabell L. Diferential regulation of c-jun and CREB by acrolein and 4-hydroxynonenal. Free Radic Biol Med 2006; 40: 21-34.
7. Finkelstein EI, Ruben J, Koot CW, Hristova M, van der Vliet A. Regulation of constitutive neutrophil apoptosis by the alpha, beta-unsaturated aldehydes acrolein and 4-hydroxynonenal. Am J Physiol Lung Cell Mol Physiol 2005; 289: L1019-28.
8. Tanel A, Averill-Bates DA. The aldehyde acrolein induces apoptosis via activation of the mitochondrial pathway. Biochim Biophys Acta 2005; 1743: 255-67.
9. Mohammad MK, Avila D, Zhang J, et al. Acrolein cyto-toxicity in hepatocytes involves endoplasmic reticulum stress, mitochondrial dysfunction and oxidative stress. Toxicol Appl Pharmacol 2012; 265: 73-82.
10. Horton ND, Biswal SS, Corrigan LL, Bratta J, Kehrer JP. Ac-rolein causes inhibitor kappaBindependent decreases in nuclear factor kappaB activation in human lung adeno-carcinoma (A549) cells. J Biol Chem 1999, 274: 9200-6.
11. Horton ND, Mamiya BM, Kehrer JP. Relationships between cell density, glutathione and proliferation of A549 human lung adenocarcinoma cells treated with acrolein. Toxicology 1997; 122: 111-22.
12. Matusheski NV, Jefery EH. Comparison of the bioactiv-ity of two glucoraphanin hydrolysis products found in broccoli, sulforaphane and sulforaphane nitrile. J Agric Food Chem 2001; 49: 5743-9.
13. Mizuno K, Kume T, Muto C, et al. Glutathione biosynthesis via activation of the nuclear factor E2-related factor 2 (Nrf2)-antioxidant-response element (ARE) pathway is essential for neuroprotective Effects of sulforaphane and 6-(methylsulfnyl) hexyl isothiocyanate. J Pharmacol Sci 2011; 115: 320-8.
14. Spitz MR, Duphorne CM, Detry MA, et al. Dietary intake of isothiocyanates: evidence of a joint Effect with glutathione S-transferase polymorphisms in lung cancer risk. Cancer Epidemiol Biomarkers Prev 2000; 9: 1017-20.
15. Zhao H, Lin J, Grossman HB, Hernandez LM, Dinney C P, Wu X. Dietary isothiocyanates, GSTM1, GSTT1, NAT2 polymorphisms and bladder cancer risk. Int J Cancer 2007; 120: 2208-13.
16. Skupinska K, Misiewicz-Krzeminska I, Lubelska K, Kas-przycka-Guttman T. The Effect of isothiocyanates on CYP1A1 and CYP1A2 activities induced by polycyclic aromatic hydrocarbons in Mcf7 cells. Toxicol In Vitro 2009; 23: 763-71.
17. Ma Q, He X. Molecular basis of electrophilic and oxida-tive defense: promises and perils of Nrf2. Pharmacol Rev 2012; 64: 1055-81.
18. Calkins MJ, Johnson DA, Townsend JA, et al. The Nrf2/ARE pathway as a potential therapeutic target in neu-rodegenerative disease. Antioxid Redox Signal 2009; 11: 497-508.
19. Evans PC. The influence of sulforaphane on vascular health and its relevance to nutritional approaches to prevent cardiovascular disease. EPMA J 2011; 2: 9-14.
20. Miao X, Bai Y, Sun W, et al. Sulforaphane prevention of diabetes-induced aortic damage was associated with the up-regulation of Nrf2 and its down-stream antioxi-dants. Nutr Metab (Lond) 2012; 9: 84.
21. Mossman T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxici-ty assays. J Immunol Methods 1983; 65: 55-63.
22. Royall JA, Ischiropoulos H. Evaluation of 2, 7-dichloro-fuorescein and dihydrorhodamine 123 as fuorescent probes for intracellular H2O2 in cultured endothelial cells. Arch Biochem Biophy 1993; 302: 348-55.
23. Devasagayam TPA. Lipid peroxidation in rat uterus. Bio-chim Biophys Acta 1986; 876: 507-14.
24. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-75.
25. Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R. Protein carbonyl groups as biomarkers of oxida-tive stress. Clin Chim Acta 2003, 329: 23-38.
26. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Bio-phys 1959; 82: 70-7.
27. Erel O. A novel automated method to measure total an-tioxidant response against potent free radical reactions. Clin Biochem 2004; 37: 112-219.
28. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005; 38: 1103-1.
29. Moron MS, Depierre JW, Mannervik B. Levels of glutathi-one, glutathione reductase and glutathione S-transfer-ase activities in rat lung and liver. Biochim Biophys Acta 1979, 582: 67-78.
30. Sun Y, Oberley LW, Ying L. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34: 497-500.
31. Habig WH, Pabst MJ, Jakoby WB. Glutathione-S-transfer-ases, the first enzymatic step in mercapturic acid formation. J Biol Chem 1974; 249: 7130-9.
32. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterisation of erythrocyte glutathi-one peroxidase. J Lab Clin Med 1967; 70: 158-69.
33. Aebi H. Catalase. In: Methods of enzymatic analysis. Bergmeyer HU (ed.). Academic Press, New York and London 1974; 673-7.
34. Rasband WS. Image J. U.S. National Institutes of Health, Bethesda, Maryland, USA. http://imagej.nih.gov/ij/. 1997-2014.
35. Ghilarducci D P, Tjeerdema RS. Fate and Effects of acrole-in. Rev Environ Contam Toxicol 1995; 144: 95-146.
36. Sakata K, Kashiwagi K, Sharmin S, et al. Increase in pu-trescine, amine oxidase, and acrolein in plasma of renal failure patients. Biochem Biophys Res Commun 2003; 305: 143-9.
37. Daimon M, Sugiyama K, Kameda W, et al. Increased urinary levels of pentosidine, pyrraline and acrolein adduct in type 2 diabetes. Endocr J 2003; 50: 61-7.
38. Calingasan NY, Uchida K, Gibson GE. Protein-bound ac-rolein: a novel marker of oxidative stress in Alzheimer's disease. J Neurochem 1999, 72: 751-6.
39. Eiserich J P, van der Vliet A, Handelman GJ, Halliwell B, Cross CE. Dietary antioxidants and cigarette smoke-induced biomolecular damage: a complex interaction. Am J Clin Nutr 1995; 62: 1490S-500S.
40. Ren S, Kalhorn T F, Slattery JT. Inhibition of human aldehyde dehydrogenase 1 by the 4-hydroxycyclophospha-mide degradation product acrolein. Drug Metab Dispos 1999; 27: 133-7.
41. Toennes SW, Schmidt K, Fandino AS, Kauert GF. A fatal human intoxication with the herbicide allyl alcohol (2-propen-1-ol). J Anal Toxicol 2002; 26: 55-7.
42. Stevens J F, Maier CS. Acrolein: sources, metabolism, and biomolecular interactions relevant to human health and disease. Mol Nutr Food Res 2008; 52: 7-25.
43. Tomic S, Brkic S, Maric D, Mikic AN. Lipid and protein oxidation in female patients with chronic fatigue syndrome. Arch Med Sci 2012; 8: 886-91.
44. Lovell MA, Xie C, Markesbery WR. Acrolein, a product of lipid peroxidation, inhibits glucose and glutamate uptake in primary neuronal cultures. Free Radic Biol Med 2000; 29: 714-20.
45. Park YS, Misonou Y, Fujiwara N, et al. Induction of thi-oredoxin reductase as an adaptive response to acrolein in human umbilical vein endothelial cells. Biochem Bio-phys Res Commun 2005; 327: 1058-65.
46. Pocernich CB, Cardin AL, Racine CL, Lauderback CM, Butterfeld DA. Glutathione elevation and its protective role in acrolein-induced protein damage in synaptoso-mal membranes: relevance to brain lipid peroxidation in neurodegenerative disease. Neurochem Int 2001; 39: 141-9.
47. Rahman I, Adcock IM. Oxidative stress and redox regulation of lung infammation in COPD. Eur Respir J 2006; 28: 219-42.
48. Ansari MA, Keller JN, Schef SW. Protective Effect of Pycnogenol in human neuroblastoma SH-SY5Y cells following acrolein-induced cytotoxicity. Free Radic Biol Med 2008; 45: 1510-9.
49. Mark RJ, Lovell MA, Markesbery WR, Uchida K, Matt-son MP. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeosta-sis and neuronal death induced by amyloid beta-pep-tide. J Neurochem 1997; 68: 255-64.
50. Liu-Snyder P, McNally H, Shi R, Borgens RB. Acrolein-me-diated mechanisms of neuronal death. J Neurosci Res 2006; 84: 209-18.
51. Çetin A, Çiftçi O, Otlu A. Protective Effect of hesperidin on oxidative and histological liver damage following carbon tetrachloride administration in Wistar rats. Arch Med Sci 2016; 12: 486-93.
52. Qiao Y, Jiang P, Gao Y. Lutein prevents osteoarthri-tis through Nrf2 activation and downregulation of infammation. Arch Med Sci 2016; DOI: 10.5114/aoms.2016.59871.
53. Kwak MK, Egner PA, Dolan PM, et al. Role of phase 2 enzyme induction in chemoprotection by dithiolethiones. Mutat Res 2001; 480-481: 305-15.
54. Ma Q. Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol 2013; 53: 401-26.
55. Toyama T, Sumi D, Shinkai Y, et al. Cytoprotective role of Nrf2/Keap1 system in methylmercury toxicity. Biochem Biophys Res Commun 2007; 363: 645-50.
56. Rajo AI, Rada P, Egea J, Rosa AO, Lopez MG, Cuadrado A. Functional interference between glycogen synthase ki-nase-3 beta and the transcription factor Nrf2 in protection against kainate-induced hippocampal cell death. Mol Cell Neurosci 2008; 39: 125-32.
57. Johnson JA, Johnson DA, Kraft AD, et al. The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration. Ann N Y Acad Sci 2008; 1147: 61-9.
58. Chen PC, Vargas MR, Pank AK, et al. Nrf2-mediated neu-roprotection in the MPTP mouse model of Parkinson's disease: critical role for the astrocyte. Proc Natl Acad Sci USA 2009; 106: 2933-8.
59. Yoon HY, Kang NI, Lee HK, Jang KY, Park JW, Park BH. Sul-foraphane protects kidneys against ischemia-reperfusion injury through induction of the Nrf2-dependent phase 2 enzyme. Biochem Pharmacol 2008; 75: 2214-23.
60. Angeloni C, Leoncini E, Malaguti M, Angelini S, Hrelia P, Hrelia S. Modulation of phase II enzymes by sulfora-phane: implications for its cardioprotective potential. J Agric Food Chem 2009; 57: 5615-22.
61. Maheo K, Morel F, Langouet S, et al. Inhibition of cyto-chromes P-450 and induction of glutathione S-transfer-ases by sulforaphane in primary human and rat hepato-cytes. Cancer Res 1997; 57: 3649-52.
62. Comer DM, Elborn JS, Ennis M. Infammatory and cyto-toxic Effects of acrolein, nicotine, acetylaldehyde and cigarette smoke extract on human nasal epithelial cells. BMC Pulm Med 2014; 14: 32.
63. O'Leary KA, de Pascual-Teresa S, Needs PW, Bao Y P, O'Brien NM, Williamson G. Effect of favonoids and vitamin E on cyclooxygenase-2 (COX-2) transcription. Mutat Res 2004; 551: 245-54.
64. Rizos CV, Liberopoulos EN, Tellis CC, Tselepis AD, Eli-saf MS. The Effect of combining rosuvastatin with sar-tans of diferent peroxisome proliferator receptor-gamma activating capacity on plasma 8-isoprostane prosta-glandin F2a levels. Arch Med Sci 2013; 9: 172-6.
65. Lee SE, Park YS. Korean Red Ginseng water extract inhibits COX-2 expression by suppressing p38 in acrole-in-treated human endothelial cells. J Ginseng Res 2014; 38: 34-9.
66. Park YS, Kim J, Misonou Y, et al. Acrolein induces cyclo-oxygenase-2 and prostaglandin production in human umbilical vein endothelial cells: roles of p38 MAP ki-nase. Arterioscler Thromb Vasc Biol 2007; 27: 1319-25.
67. Woo KJ, Kwon TK. Sulforaphane suppresses lipopolysac-charide-induced cyclooxygenase-2 (COX-2) expression through the modulation of multiple targets in COX-2 gene promoter. Int Immunopharmacol 2007; 7: 1776-83.
68. Zhou J, Joplin DG, Cross JV, Templeton DJ. Sulforaphane inhibits prostaglandin E2 synthesis by suppressing mi-crosomal prostaglandin E synthase 1. PLoS One 2012; 7: e49744.
69. Heiss E, Herhaus C, Klimo K, Bartsch H, Gerhauser C. Nuclear factor kappa B is a molecular target for sulfora-phane-mediated anti-infammatory mechanisms. J Biol Chem 2001; 276: 32008-15.
70. Rose P, Won YK, Ong CN, Whiteman M. Beta-phenylethyl and 8-methylsulphinyloctyl isothiocyanates, constituents of watercress, suppress LPS induced production of nitric oxide and prostaglandin E2 in RAW 264.7 macro-phages. Nitric Oxide 2005; 12: 237-43.